These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17328890)

  • 21. A novel PPARgamma agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways.
    Park JY; Bae MA; Cheon HG; Kim SS; Hong JM; Kim TH; Choi JY; Kim SH; Lim J; Choi CH; Shin HI; Kim SY; Park EK
    Biochem Biophys Res Commun; 2009 Jan; 378(3):645-9. PubMed ID: 19059209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.
    Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ
    J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.
    Kim MH; Ryu SY; Bae MA; Choi JS; Min YK; Kim SH
    Food Chem Toxicol; 2008 Nov; 46(11):3375-82. PubMed ID: 18786594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor activator of nuclear factor-kappa B ligand induces osteoclast formation in RAW 264.7 macrophage cells via augmented production of macrophage-colony-stimulating factor.
    Islam S; Hassan F; Tumurkhuu G; Dagvadorj J; Koide N; Naiki Y; Yoshida T; Yokochi T
    Microbiol Immunol; 2008 Dec; 52(12):585-90. PubMed ID: 19120972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
    Tsuji-Naito K
    Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
    Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
    Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
    Sugawara K; Hamada M; Hosoi S; Tamaoki T
    Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of calcitonin gene-related peptide on bone resorption mediated by interleukin-1.
    Zhang WZ; Yu SF; Zheng LF
    Chin Med J (Engl); 1994 May; 107(5):351-4. PubMed ID: 7924575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired osteoclastogenesis by staphylococcal lipoteichoic acid through Toll-like receptor 2 with partial involvement of MyD88.
    Yang J; Ryu YH; Yun CH; Han SH
    J Leukoc Biol; 2009 Oct; 86(4):823-31. PubMed ID: 19602669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action.
    Idris AI; Ralston SH; van't Hof RJ
    Eur J Pharmacol; 2009 Jan; 602(2-3):215-22. PubMed ID: 19046964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification, structural determination, and biological activity of bovine and canine calcitonin receptor-stimulating peptides.
    Katafuchi T; Hamano K; Minamino N
    Biochem Biophys Res Commun; 2004 Jan; 313(1):74-9. PubMed ID: 14672700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2.
    Ogata Y; Kukita A; Kukita T; Komine M; Miyahara A; Miyazaki S; Kohashi O
    J Immunol; 1999 Mar; 162(5):2754-60. PubMed ID: 10072521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
    Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
    Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central and peripheral cardiovascular actions of adrenomedullin 5, a novel member of the calcitonin gene-related peptide family, in mammals.
    Takei Y; Hashimoto H; Inoue K; Osaki T; Yoshizawa-Kumagaye K; Tsunemi M; Watanabe TX; Ogoshi M; Minamino N; Ueta Y
    J Endocrinol; 2008 May; 197(2):391-400. PubMed ID: 18434369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone.
    Lerner UH
    J Musculoskelet Neuronal Interact; 2006; 6(1):87-95. PubMed ID: 16675892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcitonin receptor-stimulating peptide-1 regulates ion transport and growth of renal epithelial cell line LLC-PK1.
    Hamano K; Katafuchi T; Kikumoto K; Minamino N
    Biochem Biophys Res Commun; 2005 Apr; 330(1):75-80. PubMed ID: 15781234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-function of the TNF receptor-like cysteine-rich domain of osteoprotegerin.
    Shin J; Kim YM; Li SZ; Lim SK; Lee W
    Mol Cells; 2008 May; 25(3):352-7. PubMed ID: 18443424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors.
    Ikegame M; Ejiri S; Ozawa H
    Bone; 2004 Jul; 35(1):27-33. PubMed ID: 15207738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.